Why the study?
Are plasma serotonin levels elevated during the acute phase of Tako-Tsubo Cardiomyopathy compared to STEMI and healthy controls?
Are plasma serotonin levels elevated during the acute phase of Tako-Tsubo Cardiomyopathy compared to STEMI and healthy controls?
Plasma serotonin levels are elevated during the acute phase of Tako-Tsubo Cardiomyopathy, similar to levels seen in STEMI, suggesting a potential role in its pathophysiology.
Answers are grounded in this paper and cite their sources.
Acute serotonin elevation in TTC should not guide care; leaves open a shared mechanism with STEMI pending prospective studies.
BACKGROUND: There is no data about the serotonergic activity during the acute phase of Tako-Tsubo Cardiomyopathy (TTC). The objective of our study was to investigate evidence of serotonin release from patients with TTC in comparison with patients with ST elevation myocardial infarction (STEMI) and healthy control subjects (HCS). METHODS AND RESULTS: Plasma serotonin levels in 14 consecutive patients with TTC were compared with those in 14 patients with STEMI and 14 HCS. Plasma serotonin levels at admission were markedly higher in patients with TTC and STEMI as compared to HCS (3.9 ± 4.6, P = 0.02 versus control; 5.7 ± 5.6, P = 0.001 versus control; and 1 ± 0.4 ng/mL, resp.). There was no difference in serotonin levels between patients with TTC and those with STEMI (P = 0.33). CONCLUSION: This finding suggests that serotonin could participate to the pathophysiology of TTC.
No takes yet. Share an insight, caveat, or question.
Laborde et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: